Education
About Us
Working with TipRanks
Follow Us
RUA Life Sciences (GB:RUA)
LSE:RUA
Total Valuation
RUA Life Sciences has a market cap or net worth of £7.91M. The enterprise value is 5.00M.
Market Cap£7.91M
Enterprise Value5.00M
Share Statistics
RUA Life Sciences has 62,060,272 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding62,060,272
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RUA Life Sciences’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is -24.31%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)-24.31%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee102.83K
Profits Per Employee25.00
Employee Count40
Asset Turnover0.44
Inventory Turnover1.25
Valuation Ratios
The current PE Ratio of RUA Life Sciences is 1275.0. RUA Life Sciences’s PEG ratio is -75.00.
PE Ratio1275.0
PS Ratio1.82
PB Ratio1.03
Price to Fair Value1.03
Price to FCF-26.69
Price to Operating Cash Flow-37.53
PEG Ratio-75.00
Income Statement
In the last 12 months, RUA Life Sciences had revenue of 4.11M and earned 1.00K in profits. Earnings per share was 0.00.
Revenue4.11M
Gross Profit3.17M
Operating Income-989.00K
Pretax Income-10.00K
Net Income1.00K
EBITDA401.00K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -215.00K and capital expenditures -62.00K, giving a free cash flow of -277.00K billion.
Operating Cash Flow-215.00K
Free Cash Flow-277.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
RUA Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.01
52-Week Price Change9.89%
50-Day Moving Average11.75
200-Day Moving Average11.90
Relative Strength Index (RSI)47.17
Average Volume (3m)148.53K
Important Dates
RUA Life Sciences upcoming earnings date is Dec 11, 2025, TBA (Confirmed).
Last Earnings DateJun 25, 2025
Next Earnings DateDec 11, 2025
Ex-Dividend Date―
Financial Position
RUA Life Sciences as a current ratio of 4.91, with Debt / Equity ratio of 14.10%
Current Ratio4.91
Quick Ratio4.23
Debt to Market Cap0.03
Net Debt to EBITDA-6.33
Interest Coverage Ratio0.00
Taxes
In the past 12 months, RUA Life Sciences has paid 11.00K in taxes.
Income Tax11.00K
Effective Tax Rate-1.10
Enterprise Valuation
RUA Life Sciences EV to EBITDA ratio is 12.37, with an EV/FCF ratio of -17.66.
EV to Sales1.21
EV to EBITDA12.37
EV to Free Cash Flow-17.66
EV to Operating Cash Flow-22.66
Balance Sheet
RUA Life Sciences has £3.57M in cash and marketable securities with £1.03M in debt, giving a net cash position of £2.54M billion.
Cash & Marketable Securities£3.57M
Total Debt£1.03M
Net Cash£2.54M
Net Cash Per Share£0.04
Tangible Book Value Per Share£0.11
Margins
Gross margin is 72.79%, with operating margin of -24.05%, and net profit margin of 0.02%.
Gross Margin72.79%
Operating Margin-24.05%
Pretax Margin-0.24%
Net Profit Margin0.02%
EBITDA Margin9.75%
EBIT Margin-0.49%
Analyst Forecast
The average price target for RUA Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast87.72%
EPS Growth Forecast―